Healthy Conversations That Matter: Clinical Treatment with Psilocybin
Who can attend?
- General public
- Faculty
- Staff
- Students
Contact
Description
Research has shown that clinical use of psilocybin can be a beneficial tool for mental health professionals in treating a variety of mental health conditions such as treatment-resistant depression, end-of-life distress, and substance-use disorders.
Join Johns Hopkins psychiatrist Mary "Bit" Yaden as she provides an update on the use of psilocybin in research and clinical settings. Submit your questions in advance for A Woman's Journey's national chair, Kelly Geer Ripken, to ask Yaden live.
Who can attend?
- General public
- Faculty
- Staff
- Students